SCHEMBL21561540

SCHEMBL21561540

Cc1cc(Nc2ncnn3ccc(CN4CC5CC[C@@H](C4)[C@H]5N)c23)ccc1Oc1ccn2ncnc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ERBB2 P04626 18/20 0.53
▸ EGFR P00533 11/20 0.53
▸ NQO2 P16083 1/20 0.48
▸ FECH P22830 1/20 0.48
▸ MYH14 Q7Z406 1/20 0.48
▸ RIPK3 Q9Y572 1/20 0.48
▸ AAK1 Q2M2I8 2/20 0.48
▸ LCK P06239 2/20 0.48
▸ CIT O14578 1/20 0.48
▸ CHEK1 O14757 1/20 0.48
▸ GAK O14976 1/20 0.48
▸ STK10 O94804 1/20 0.48
▸ PRKD3 O94806 1/20 0.48
▸ ABL1 P00519 1/20 0.48
▸ FYN P06241 1/20 0.48
▸ YES1 P07947 1/20 0.48
▸ LYN P07948 1/20 0.48
▸ RET P07949 1/20 0.48
▸ HCK P08631 1/20 0.48
▸ SRC P12931 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21561448 1.00 ERBB2 (0.53) ERBB2EGFRNQO2FECHMYH14
SCHEMBL21561473 1.00 ERBB2 (0.53) ERBB2EGFRNQO2FECHMYH14
SCHEMBL21561472 0.89 ERBB2 (0.50) ERBB2EGFRNQO2FECHMYH14
SCHEMBL21561449 0.89 ERBB2 (0.50) ERBB2EGFRNQO2FECHMYH14
SCHEMBL21561484 0.89 EGFR (0.67) ERBB2EGFRAAK1LCKKDR
SCHEMBL21561471 0.89 ERBB2 (0.51) ERBB2EGFRNQO2FECHMYH14
SCHEMBL23096271 0.87 EGFR (0.57) ERBB2EGFRAAK1LCKCIT
SCHEMBL21561500 0.87 EGFR (0.57) ERBB2EGFRAAK1LCKCIT
SCHEMBL21561501 0.87 ERBB2 (0.56) ERBB2EGFRAAK1LCKCIT
SCHEMBL21561457 0.87 EGFR (0.57) ERBB2EGFRAAK1LCKCIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019214651-A1 PYRROLO[2,1-F][1,2,4]TRIAZINE DERIVATIVES SERVING AS SELECTIVE HER2 INHIBITORS AND APPLICATION THEREOF 南京明德新药研发有限公司 (CN) 2019-11-14 — — WO disclosed
Send feedback